Active Pharmaceutical Ingredients Market Research Report Information By Manufacturing Process (Captive Manufacturing and Contract Manufacturing), By Type of Synthesis (Synthetic and Biotech), By API Formulation (Generic API and Branded/Innovative API), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, and others), By Molecules (Large Molecule and Small Molecule), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market
Market Research Future Insights
The global API market is expected to register a CAGR of ~7.98% from 2022 to 2030 and hold a value of over USD 512.13 billion by 2030.
The active pharmaceutical ingredients (API) market refers to the chemical compounds that are used to produce pharmaceutical drugs. These compounds are biologically active and are responsible for the therapeutic effects of the drugs.
The COVID-19 pandemic has had a significant impact on the API market. The disruptions in the supply chain and manufacturing processes have caused shortages of essential drugs in many countries. Many pharmaceutical companies are now looking to reduce their dependence on foreign suppliers and increase domestic production of APIs.
Get Free Sample PDF Brochure @
https://www.marketresearchfuture.com/sample_request/1385
Market Segmentation
The Global API market has been segmented into based on manufacturing process, type, formulation, application and molecules.
Based on Manufacturing Process: Captive Manufacturing and Contract Manufacturing
Based on Type: Synthesis Synthetic and Biotech
Based on Formulation: Generic API, Branded/Innovative API
Based on Application: Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology
Based on Molecules: Large Molecule and Small Molecule
Keyplayers
Some of the top key market players are Sanofi SA (France), Hoffmann-La Roche Ltd. (Switzerland), Pfizer Inc (US), Abbott (US), Bayer AG (UK) Merck & Co. Inc (US), GlaxoSmithKline Plc (UK), Novartis AG (UK) and Teva Pharmaceutical Industries Ltd. (Israel)
Regional Analysis
Regionally, the API market is dominated by Asia-Pacific, particularly India and China, which are major producers of generic drugs. The increasing demand for affordable drugs in developing countries, coupled with the presence of a large number of API manufacturers, is driving the growth of the market in this region.
Browse In-depth Market Research Report (157 Pages) on active pharmaceutical ingredients:
https://www.marketresearchfuture.com/reports/active-pharmaceutical-ingredients-market-1385
North America and Europe are also major markets for APIs, driven by the increasing demand for generic drugs and biologics. The increasing prevalence of chronic diseases such as cancer and diabetes is also fueling the demand for APIs in these regions.
Discover More Research Reports on Healthcare Industry by Market Research Future:
Chronic Disease Management Market Research Report Information By Solution (Educational Solution, Implementation Solution, Consulting Solution and others), Delivery Mode (Cloud-Based, On-Premises and Web-Based), Application (Arthritis, Cardiovascular Disease, Cancer, Diabetes and others), End-User (Providers, Payers), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.
Organ-on-a-chip Market Research Report: By Organ Type (Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Human-on-Chip), By Application (Drug Discovery, Toxicology Research, Others) and By End-User (Pharmaceutical Companies, Research Organizations, Others) – Forecast to 2030
Small Molecule API Market Research Report: Information By Types (Synthetic/Chemical API and Biological API), By Application (Cardiovascular, Oncology, Diabetes, and Immunological Disorders), By Manufacturing Method (In-House and Contract), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com